Dr. Raja B. Singh is the Chief Science & Innovation Officer at BioAro Inc., spearheading development of novel AI-driven platforms for Precision Medicine, drug discovery, repurposing, and pharmacogenomics. A physician by training, Raja has extensive clinical, scientific, administrative and operational expertise in development & integration of multi-OMICS testing with advanced AI/ML/LLM/SLM and Quantum computing for ClinicalCare. His leadership at BioAro has led to the development of state-of-the-art sequencing facility, PanOmiQ platform, BioSport and BioMYND programs. These are currently being deployed for developing in-silico drug design & simulation of clinical trials (using digital twins) to optimize therapeutic efficacy & reduce drug discovery timelines through blockchain enabled data governance, security, and interoperability.